Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence

Polymyxin B has resurged in recent years as a last resort therapy for Gram-negative multidrug-resistant (MDR) and extremely drug resistant (XDR) infections. Understanding newer evidence on polymyxin B is necessary to guide clinical decision making. Here, we present a literature review of polymyxin B...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Crit Care Res Pract
Hlavní autoři: Garg, Suneel Kumar, Singh, Omender, Juneja, Deven, Tyagi, Niraj, Khurana, Amandeep Singh, Qamra, Amit, Motlekar, Salman, Barkate, Hanmant
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2017
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518490/
https://ncbi.nlm.nih.gov/pubmed/28761764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3635609
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky